Cebu Pacific Back To Full Year Profit After Pandemic Losses

Cebu Pacific soars to new heights with Php 90.6 billion in revenue for 2023, marking a 60% increase from the previous year!

FDA DG Assists Small Businesses With BBMSME Program, Joins First Lady in Tuguegarao

Food and Drug Administration Director General Dr. Samuel Zacate partners with Tuguegarao Mayor to empower local entrepreneurs through Bigyan-Halaga, Bangon Micro, Medium and Small Enterprises program.

Tala’s Iona Inigo-Mayo Shares Its Empowerment On The Organization And Its Customers

Gender-inclusive workplaces drive success! Tala empowers women, fostering leadership & financial independence, transforming lives and communities globally.

HONOR PH Introduces HONOR X7b, Another High-Quality Phone Without Breaking Your Wallet

HONOR Philippines locally debuts the durable, budget-friendly HONOR X7b, boasting impressive features like extended battery life and superb display.

Sec. Dela Peña: DOST To Look For More Participants In VCO Clinical Trial

0

Sec. Dela Peña: DOST To Look For More Participants In VCO Clinical Trial

0

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

The Department of Science and Technology (DOST) will look for more participants in the community-based study on the effectiveness of virgin coconut oil (VCO) in treating coronavirus disease (Covid-19) patients, which it has been conducting at the Santa Rosa Community Hospital in Laguna.

During the “Laging Handa” public briefing, Secretary Fortunato dela Peña said most of the participants in this study―with mild cases of Covid-19―were already sent home.

He, however, did not specify how many recovered and the total number of participants in this study.

“We want to add the number of participants. For 28 days, VCO will be included in their three meals,” he said during the briefing.

Dela Peña earlier said the target number of participants is 90.

On Tuesday, he said half of them would be provided with VCO, to compare the performance with the other 45 persons who would not be given the VCO.

Participants should give their consent, and those who will be provided with VCO should be those without a high cholesterol level, he added.

The DOST also planned to do a hospital-based clinical trial to assess the possible benefits of VCO if given to patients with moderate to severe Covid-19.

This has not started yet, and will be done at the Philippine General Hospital, dela Peña said.

He earlier said VCO has antiviral properties and has no harmful effects and toxicity. (PNA)